ArticleMolecular cancer therapeutics2021

Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models.

Keith T Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.